期刊文献+

阿奇霉素对小儿支原体肺炎患者C反应蛋白与心肌酶含量影响及临床疗效 被引量:36

Effects of azithromycin on C-reactive protein and myocardial enzyme levels in patients with mycoplasma pneumonia and its clinical effects
原文传递
导出
摘要 目的:通过检测经阿奇霉素治疗前后支原体肺炎(MP)患儿血清心肌酶及C反应蛋白(CRP)活性,探讨阿奇霉素的临床疗效。方法:观察组144例MP患儿根据病情分成重症MP组(60例)和轻症MP组(84例),另选同期108例健康儿童作为对照组,MP患儿接受阿奇霉素治疗,对比分析治疗前后小儿血清心肌酶[天冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)、肌酸激酶(CK)及其同工酶(CK-MB)]与CRP的活性。结果:治疗前,重症MP组、轻症MP组患儿血清AST、LDH、CK、CKMB及CRP均高于对照组(P<0.05),除轻症MP组与对照组小儿的CK值比较无统计学差异(P>0.05)外,其余皆具有统计学差异(P<0.05)。经阿奇霉素治疗后,重症MP组、轻症MP组患儿血清AST、LDH、CK-MB及CRP均较治疗前明显降低(P<0.05)。治疗总有效率为94.4%,不良反应轻微。结论:重症肺炎患儿可能存在心肌损伤,阿奇霉素在治疗MP肺炎的同时能更好地治疗MP肺炎并发的心肌损伤。 OBJECTIVE To investigate the clinical efficacy of azithromycin by detecting serum myocardial enzymes and C-re- active protein (CRP) activity in patients with mycoplasma pneumonia (MP) before and after treatment with azithromycin. METHODS 144 cases of observation group were divided into 60 cases with severe MP group and 84 cases with mild MP group. At the same period 108 cases of healthy children were enrolled as the control group. CRP and myocardial enzyme inclu- ding aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK) and its co-workers enzyme (CK- MB) were compared and analyzed before and after treatment. RENULTS Before treatment, in severe MP group, mild MP group the serum AST, LDH, CK, CK-MB and CRP were higher than those of the control group(P〈0. 05), except for mild MP group and the control group CK levels in children was no significant difference (P〈0.05). After azithromycin treatment, serum AST, LDH, CK-MB and CRP in severe MP group, mild MP group were significantly decreased (P〈0. 05). The total effective rate was 94. 4%, adverse reactions were mild. CONCLUSION Children with severe pneumonia may exist myocardial iniury, AST, LDH, CK-MB and CRP can be used for evaluation of children with pneumonia and as concomitant important indi- cators of myocardial injury, azithromycin can significantly and effectively reduce these indicators.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第7期562-564,共3页 Chinese Journal of Hospital Pharmacy
关键词 阿奇霉素 支原体肺炎 小儿 心肌酶 C反应蛋白 azithromycin mycoplasma pneumonia children enzymes C-reactive protein
  • 相关文献

参考文献14

  • 1Akaike H, Miyashita N, Kubo M, et al. In vitro activities of 11 antimicrobial agents against macrolideresistant Mycoplas- ma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study [J]. Jpn J Infect Dis, 2012, 65 (6) : 535-538.
  • 2Shah SS, Test M, Sheffler-Collins S, etal. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia [J]. J Hosp Med, 2012, 7(4):311-317.
  • 3Pientong C, Ekalaksananan T, Teeratakulpisarn J, et al. A- typical bacterial pathogen infection in children with acute bron- chiolitis in northeast Thailand [J]. J Mierohiol Immunol In- fect, 2011, 44(2) :95-100.
  • 4Christie J. Diagnosing Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia[J]. Am J Nurs, 2013, 113(5):65-65.
  • 5Ma HM, Ip M, Hui E, et al. Role of atypical pathogens in nursing home-acquired pneumonia [J]. J Am Med Dir Assoc, 2013, 14(2):109-113. W.
  • 6aites KB, Dully LB, B6b6ar CM, et al. Standardized meth- ods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum [J]. J Clin Microbiol, 2012, 50(11) :3542-3547.
  • 7高惠,罗征秀,罗健,徐秀娟,刘恩梅,符州.儿童肺炎支原体肺炎后遗症临床危险因素分析[J].重庆医科大学学报,2013,38(2):165-167. 被引量:27
  • 8Remmelts HH, Meijvis SC, Biesma DH, et al. Dexametha- sone downregulates the systemic eytokine response in patients with community-acquired pneumonia [J]. Clin Vaccine Immu- nol, 2012, 19(9):1532- 1538.
  • 9刘金荣,彭芸,杨海明,李惠民,赵顺英,江载芳.难治性肺炎支原体肺炎的表现特征和判断指标探讨[J].中华儿科杂志,2012,50(12):915-918. 被引量:182
  • 10Sφarensen CM, Schonning K, Rosenfeldt V. Clinical character- istics of children with Mycoplasma pneumoniae infection hospi- talized during the Danish 2010- 2012 epidemic [J]. Dan Med J, 2013, 60(5):A4632.

二级参考文献29

  • 1王玉花,陈俊杰,陈本美,张毕奎.液质联用测定血浆中阿奇霉素及其人体药动学和相对生物利用度研究[J].中国药学杂志,2006,41(1):51-54. 被引量:14
  • 2杜东红,田洪青,楼小航.红霉素醋酸锌凝胶和软膏治疗寻常型痤疮[J].中国新药与临床杂志,2006,25(4):286-288. 被引量:15
  • 3赵恒利,崔晞,王本杰,卜凡龙,郭瑞臣.HPLC-MS法研究阿奇霉素片剂与胶囊的人体相对生物利用度及药代动力学[J].药物分析杂志,2006,26(3):304-307. 被引量:3
  • 4胡亚美 江载芳.实用儿科学(下册)[M]7版[M].北京:人民卫生出版社,2002.1537.
  • 5Najib NM, Idkaidek N,Ghanem IE, et al. Bioequivalenee assessment of azomycin (Julphar, UAE) as compared to zithromax fizer, USA. 2twobrands of azithromycin2in healthy human volunteers[J]. Biopharm Drug Dispos,2001,22(1) :15.
  • 6Fouda HG, Schneider RP. Quantitative determination of the antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with a standard HPLC-electrochemical method[J]. Ther Drug Monit, 1995, 17 (2) : 179.
  • 7Shah VP, Midha KK, Dighe S, et al. Analytical methods validation., bioavailability, bioavailability, bioequivalence and pharmacokinetic studies[J]. Pharm Sci, 1992,81:309.
  • 8Lingyun Chen, Feng Qin, Yuanyuan Ma, et al. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-eleetrospray ionization mass spectrometry and its application in a pharmacokinetic study [J]. Journal of Chromatography B, 2007,855: 255-261.
  • 9Katsambas A, Papakonstantinou A. Acne: systemic treatment [J]. Clin Dematol, 2014, 22(5) :412-418.
  • 10Tamura A, Matsubara K,Tanaka T,et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect, 2008, 57:223-228.

共引文献208

同被引文献289

引证文献36

二级引证文献436

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部